Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of JDOC will - over the next 2 Weeks and hit - by . In that time frame, JDOC's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
JDOC shares fell -1.16% in Friday, September 11, 2026's trading session, dropping from a previous close of $61.43 to move at $60.72. The stock demonstrated notable intraday movement (see JDOC's key stats for a full breakdown), fluctuating between $60.72 and $60.72, a 0 trading range. While recent weeks have seen some volatility, JDOC has managed to secure a -3.27% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 21 shares changing hands, 90 fewer than the previous session. This amounted to $1.28K in total market activity.
Will JDOC Continue Its Trend?
According to analyst ratings and projections for JDOC, JPMorgan Healthcare Leaders ETF shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for JDOC currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 18 negative trading days within the past 30 sessions. Based on the JDOC stock forecast, now is not the best time to buy JDOC stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on JDOC covering social and institutional perspectives.
JDOC Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into JDOC's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 30.75% to 44.22%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 51.26%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.48%, maintains a neutral outlook for the long term. Insights into JDOC's shareholder base show how institutional investors are positioning themselves during these momentum shifts

